Pharma marketing is shifting from a product-centered approach to one driven by data and engagement, according to Kamya Elawadhi, chief client officer at Doceree. In an interview with Fierce Pharma ...

The customer experience has never been more important for pharmaceutical and life sciences companies. From patients and providers to caregivers and payers, customer expectations have become ...

Amit Singh is a global leader specializing in transformative AI and Master Data Management solutions. Please reach out to him on LinkedIn. In the highly regulated pharmaceutical industry, companies ...

Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics ...

The pharmaceutical industry is on the cusp of an AI-driven revolution. By 2030, AI-powered drug discovery is projected to be a $9.1 billion market, growing at a staggering 29.7% CAGR. AI promises to ...

Strengthen information governance with clear policies for data classification, retention, and legal holds to meet industry regulations and ensure defensibility. Embed compliance and collaboration ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...